|
G0452 |
 |
Molecular pathology procedure; physician interpretation and report
| short | Molecular pathology interpr |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 26.0 | 0.37 | 0.14 | 0.14 | 0.02 | 0.53 | 0.53 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 6.0 | 3 Date of Service Edit: Clinical | Clinical: Data | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
G0453 |
|
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
| short | Cont intraop neuro monitor |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.6 | 0.29 | 0.29 | 0.05 | 0.94 | 0.94 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 40.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup | | OPH | 10.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup |
|
|
|
|
G0454 |
|
Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist
| short | Md document visit by npp |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.18 | 0.07 | 0.07 | 0.01 | 0.26 | 0.26 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 2 Date of Service Edit: Policy | Nature of Service/Procedure | | OPH | 1.0 | 2 Date of Service Edit: Policy | Nature of Service/Procedure |
|
|
|
|
G0455 |
|
Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen
| short | Fecal microbiota prep instil |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 1.34 | 0.6 | 2.16 | 0.13 | 2.07 | 3.63 | 000 |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 2 Date of Service Edit: Policy | Nature of Service/Procedure | | OPH | 1.0 | 2 Date of Service Edit: Policy | Nature of Service/Procedure |
|
|
|
|
G0456 |
|
Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters
| short | Neg pre wound <=50 sq cm |
|
|
|
G0457 |
|
Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters
| short | Neg pres wound >50 sq cm |
|
|
|
G0458 |
|
Low dose rate (ldr) prostate brachytherapy services, composite rate
| short | Ldr prostate brachy comp rat |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
G0459 |
|
Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
| short | Telehealth inpt pharm mgmt |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.95 | 0.18 | 0.18 | 0.05 | 1.18 | 1.18 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
G0460 |
|
Autologous platelet rich plasma for chronic wounds/ulcers, including phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment
| short | Autologous prp for ulcers |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 2.25 | 0.99 | 3.39 | 0.37 | 3.61 | 6.01 | 000 |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
G0461 |
|
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
| short | Immunohisto/cyto chem 1st st |
|
|
|
G0462 |
|
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)
| short | Immunohisto/cyto chem add |
|
|
|
G0463 |
|
Hospital outpatient clinic visit for assessment and management of a patient
| short | Hospital outpt clinic visit |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 0.0 | 3 Date of Service Edit: Clinical | CMS Policy | | OPH | 4.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
|
G0464 |
|
Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)
| short | Colorec ca scr, sto bas dna |
|
|